Seiler T, Kriegerowski M, Kahle G, Wollensak J
Augenklinik, Freien Universität Berlin im Klinikum Charlottenburg.
Klin Monbl Augenheilkd. 1991 Sep;199(3):153-9. doi: 10.1055/s-2008-1046063.
Results of excimer laser keratomileusis in 26 myopic sighted eyes are presented. The follow-up was at least 9 months. The base-line refraction was -4.48 +/- 1.81 D (range: -1.4 to -9.25 D). After 3 months 85% were within +/- 1 D from the intended refraction. The such defined success rate after 6 months was 87.5%, after 9 months 88%, and after 12 months 92%. One month after surgery we found an overcorrection of +1.45 +/- 1.22 D decreasing to +0.27 +/- 0.94 D at three months, becoming an undercorrection of -0.24 +/- 0.76 D after six, and -0.32 +/- 0.69 D after nine months, and of -0.36 +/- 0.6 D after one year. Stability within the measurement error (+/- 0.25 D) appeared in 79% of the treated eyes six months after treatment. Three patients have been excluded from the study group because they did not follow the protocol. Subepithelial haze occurred in all patients, becoming most intense after 3 months, gradually clearing over the next months. With appropriate steroid medication, the refractive effect may be modulated. Complications as steroid glaucoma, recurrent erosion, loss of acuity, or extensive corneal scarring seem to be very rare.
本文呈现了26只近视眼睛的准分子激光原位角膜磨镶术的结果。随访时间至少为9个月。基线屈光度为-4.48±1.81 D（范围：-1.4至-9.25 D）。3个月后，85%的眼睛屈光度在预期屈光度±1 D范围内。6个月、9个月和12个月时，如此定义的成功率分别为87.5%、88%和92%。术后1个月我们发现过矫+1.45±1.22 D，3个月时降至+0.27±0.94 D，6个月后变为欠矫-0.24±0.76 D，9个月后为-0.32±0.69 D，1年后为-0.36±0.6 D。治疗6个月后，79%的治疗眼在测量误差（±0.25 D）范围内保持稳定。3名患者因未遵循方案被排除在研究组之外。所有患者均出现上皮下混浊，3个月时最为严重，在接下来的几个月中逐渐消退。使用适当的类固醇药物可调节屈光效果。类固醇性青光眼、复发性糜烂、视力丧失或广泛角膜瘢痕等并发症似乎非常罕见。
